Oliver Mobasser

London
  • 99 Bishopsgate
  • London EC2M 3XF
  • United Kingdom
 
 

Oliver Mobasser is an associate in the Corporate Department of Latham & Watkins' London office and a member of the Technology Transactions Practice. Mr. Mobasser has broad experience advising on data privacy matters, commercial contracts, intellectual property, technology, and M&A transactions. Mr. Mobasser has particular expertise advising multinational pharmaceutical and medical technology companies on commercial contracts, intellectual property matters, and life sciences regulation.

Prior to joining Latham, Mr. Mobasser was a solicitor at a leading firm in Dublin, Ireland, as well as completing a secondment as in-house counsel for Shire Pharmaceuticals. Mr. Mobasser completed his legal studies at University College Dublin.

Mr. Mobasser’s experience covers:

  • Life sciences regulation
  • Technology transactions
  • Intellectual property
  • Commercial contracts and collaborations
  • Data protection

Mr. Mobasser’s representative experience includes advising:

  • A leading global pharmaceuticals company on long-term supply arrangements related to a complex carve-out transaction
  • A leading global pharmaceuticals company on contracts and issues relating to a divestment of assets
  • A medical technology and oncology company on the acquisition of an international group of hospitals and the potential use of data following acquisition
  • A multinational pharmaceutical company on an innovative and complex portfolio pricing deal*
  • A leading global consultancy firm on its privacy impact assessment process to minimize privacy and security risks and achieve compliance with global privacy laws for new systems and tools
  • A private equity firm on intellectual property, information technology, and data privacy diligence related to its acquisition of a company operating automatic number plate recognition (ANPR) car parks
  • A private equity firm on commercial contracts diligence related to its acquisition of a manufacturer of train components
  • Various pharmaceutical companies in relation to pricing and reimbursement, drafting managed entry agreements, compassionate use and early access agreements*
  • A leading technology company on the classification of lifestyle and medical software and regulatory requirements for medical devices*
  • A number of multinational pharmaceutical companies on clinical trials and access obligations and risks following early termination*
  • Various clients on GDPR implementation and operation, e-commerce, and electronic marketing, including cross-border data transfers, standard contractual clauses, employee data access requests, breach notifications, and processor contracts*

*Matter handled prior to joining Latham

 

 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.